CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $363,000 | -59.9% | 43,642 | -64.4% | 0.00% | -100.0% |
| Q3 2019 | $905,000 | -68.7% | 122,572 | -21.6% | 0.00% | -66.7% |
| Q3 2018 | $2,891,000 | -18.6% | 156,248 | +0.6% | 0.00% | -25.0% |
| Q2 2018 | $3,551,000 | -39.1% | 155,317 | -24.3% | 0.00% | -33.3% |
| Q1 2018 | $5,834,000 | -10.2% | 205,060 | -33.4% | 0.01% | 0.0% |
| Q4 2017 | $6,498,000 | +110.6% | 307,818 | +81.3% | 0.01% | +100.0% |
| Q3 2017 | $3,085,000 | +234.6% | 169,799 | +185.3% | 0.00% | +200.0% |
| Q2 2017 | $922,000 | – | 59,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |